Genitourinary Radiology: Page 23

Rethinking Ga-68 PSMA-11 PET/CT for bone metastases

By Wayne Forrest

Researchers from the University of California, Los Angeles say it is time to reconsider guidelines in favor of broader use of gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) PET/CT to detect bone metastases in prostate cancer patients, based on findings in their study published September 20 in the Journal of Nuclear Medicine.

September 25, 2019

Guerbet, IBM partner on AI for prostate cancer

By AuntMinnie.com staff writers

Contrast developer Guerbet and IBM Watson Health have signed an agreement to develop and commercialize artificial intelligence (AI) software for diagnosing prostate cancer.

September 23, 2019

3D VR models improve kidney-sparing surgery outcomes

By Abraham Kim

Examining 3D virtual reality (VR) models during presurgical planning for robotic-assisted partial nephrectomy led to reductions in operating time, blood loss, and hospital length of stay compared with planning based on MRI and CT scans alone in a new study, published online September 18 in JAMA Network Open.

September 17, 2019

ASTRO: SABR generates immune response to prostate cancer

By Brian Casey

CHICAGO - The use of stereotactic ablative radiotherapy (SABR) to treat men with oligometastatic prostate disease not only destroyed tumors but also seemed to promote an immune response in the body to fight cancer in a new study, presented at this week's American Society for Radiation Oncology (ASTRO) meeting.

September 15, 2019

ASTRO: Is hormone therapy after prostate surgery needed?

By Brian Casey

CHICAGO - Men who have undergone surgery for prostate cancer may not need long-term hormone therapy if they have low levels of prostate-specific antigen after their procedure, according to research presented Sunday at the American Society for Radiation Oncology (ASTRO) meeting.

September 15, 2019

Ga-68 PSMA PET/MRI, mpMRI work for prostate cancer analysis

By Wayne Forrest

Prostate cancer patients at intermediate or high risk of advanced disease can benefit from either gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/MRI or multiparametric MRI (mpMRI) alone to diagnose specific features of their disease, according to a study published September 10 in Radiology.

September 11, 2019

AI, radiomics predict prostate cancer aggressiveness

By Erik L. Ridley

The combination of an artificial intelligence (AI) algorithm and radiomics can accurately and automatically predict the aggressiveness of prostate cancer on dynamic contrast-enhanced MRI exams prior to biopsy, according to research published online September 5 in Clinical Radiology.

September 9, 2019

NaF-PET/CT does well in detecting prostate metastases

By Wayne Forrest

Nuclear medicine physicians showed high accuracy and consistency when reading sodium fluoride (NaF)-PET/CT scans of patients with prostate cancer metastases in a new study, published online September 3 in the Journal of Nuclear Medicine.

September 5, 2019

Ultrasound + photoacoustic imaging spot prostate cancer

By Kate Madden Yee

A dual-modality imaging approach that combines ultrasound and photoacoustic imaging to visualize the prostate appears to improve the diagnosis of prostate cancer, according to a study published online August 28 in Science Translational Medicine.

August 28, 2019

ViewRay touts clinical trial on MRI-guided radiotherapy

By AuntMinnie.com staff writers

Image-guided radiation therapy vendor ViewRay is highlighting a prospective clinical trial that confirmed the safety of using its MRIdian MRI-guided radiation therapy to treat prostate cancer.

August 18, 2019

Concerns grow over CT radiation for kidney stones

By Abraham Kim

Clinicians need to be more judicious when it comes to using CT for kidney stones, say researchers from Washington. In a new study published online in Urology, they report that patients with active stone disease are exposed to roughly 10 times more CT radiation per year than individuals without kidney stones.

August 14, 2019

MRA screening finds aneurysms related to kidney disease

By Wayne Forrest

Can MR angiography (MRA) be effective in screening for brain aneurysms among patients with autosomal dominant polycystic kidney disease? A new study published online July 30 in the Clinical Journal of the American Society of Nephrology backs the modality, even when no symptoms are present.

July 30, 2019

Previous Page

Page 23 of 93

Next Page